Clal Insurance Enterprises Holdings Ltd
InsurancePosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1376192
Tel-aviv, L3
Position in TEVA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,158,008,760
-$9,373,388 QoQ
Shares Held
38,446,506
+2.8% QoQ
Ownership
3.30%
of shares outstanding
% of Portfolio
11.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Clal Insurance Enterprises Holdings Ltd holds $1,158,008,760 across 1 Drug Manufacturers - Specialty & Generic name. TEVA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
38,446,506 | $1,158,008,760 |
All Filings in TEVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,158,008,760 | 38,446,506 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $1,167,382,148 | 37,404,106 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $636,030,996 | 31,486,683 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $542,398,567 | 32,362,683 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $580,894,825 | 37,794,068 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $858,739,516 | 38,962,773 | Shares | Defined | 2025-02-06 | |
| 2024-09-30 | $622,479,492 | 34,543,812 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $525,511,821 | 32,339,189 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $406,288,504 | 28,794,366 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $342,475,127 | 32,804,131 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $312,269,623 | 30,614,669 | Shares | Defined | 2023-11-06 | |
| 2023-06-30 | $238,058,457 | 31,614,669 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $166,695,644 | 18,835,666 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $168,078,553 | 18,429,666 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $156,612,601 | 19,406,766 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $142,600,000 | 18,962,766 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $164,687,134 | 17,538,566 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $140,483,913 | 17,538,566 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $171,994,432 | 17,658,566 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $156,754,639 | 15,833,802 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $166,235,915 | 14,405,192 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $140,650,602 | 14,575,192 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $125,324,099 | 13,909,445 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $202,440,980 | 16,418,571 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $119,555,867 | 13,313,571 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||